Navigate

Wire Stories

OliX Pharmaceuticals Administers First Patient in Phase 1 Clinical Study of RNAi Therapeutic OLX72021 for Androgenic Alopecia

SUWON, South Korea--(BUSINESS WIRE)--#AndrogenicAlopecia--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced…

3 years ago

IperionX to Produce Titanium Components for Ford Motor Company

CHARLOTTE, N.C.--(BUSINESS WIRE)--$IPX #3Dprinting--IperionX Limited (NASDAQ:IPX, ASX: IPX) has agreed a Scope of Work (“SoW”)…

3 years ago

ZAP Surgical Announces Upcoming Installation of Novel Non-Invasive Brain Tumor Treatment System in South Korea

Dankook University Hospital to Become the First in Korea to Offer Next-Generation ZAP-X Gyroscopic Radiosurgery…

3 years ago

Promega Commits to 100% Renewable Electricity by 2025

Biotechnology company announces pledge in annual Corporate Responsibility Report MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation has committed…

3 years ago

Enevate Announces New Production License Agreement with JR Energy Solution, Enabling Further Scale-up of its Breakthrough Battery Technology

IRVINE, Calif.--(BUSINESS WIRE)--Enevate, a pioneering battery innovation company featuring extreme fast charge and high energy…

3 years ago

Global Employee Engagement Is on the Rise, Along with Stress; Highest Levels Found Among American, Canadian and East Asian Workers

WASHINGTON--(BUSINESS WIRE)--#SOGW2023--Gallup’s latest State of the Global Workplace report finds that employee engagement and job…

3 years ago

HighField Biopharmaceuticals Receives US FDA IND Clearance for Phase 1 Trial of Immunoliposome HF158K1 for Treatment of HER2 low and HER2+ Cancers

The company’s groundbreaking drug encapsulated immunoliposomes may represent a significant improvement over existing antibody drug…

3 years ago

HKSTP Reinforces Vision to Achieve Net-Zero Emissions by 2045 and Help Hong Kong Lead the Region in Green Tech and Green Finance

HKSTP is the first statutory body in Hong Kong to commit to net-zero by 2045…

3 years ago

CORRECTING and REPLACING Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03 (Perfluorohexyloctane Ophthalmic Solution) For the Treatment of Dry Eye Disease in Japan

OSAKA, Japan & HEIDELBERG, Germany & CAMBRIDGE, Mass.--(BUSINESS WIRE)--#NOV03--Fifth paragraph, the number in the quote…

3 years ago

MCO to Acquire Fairwords

AI-Powered Communications Protection Software Becomes Part of MCO's Global Compliance Offerings NEW YORK--(BUSINESS WIRE)--#asiarisk--MyComplianceOffice Inc…

3 years ago

Search